Medicine
Technescan HDP 3.15 mg powder for injection
Technescan HDP 3.15 mg powder for injection is a prescription medicine containing Oxidronate for intravenous use, marketed by Curium, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Technescan HDP is available as: • 5 vials per carton (NDC 69945-091-20) • 30…
Key facts
- Active ingredient (INN)
- Oxidronate
- Brand
- Technescan HDP
- Strength
- 3.15 mg
- Dosage form
- Powder for injection
- Route
- Intravenous
- Packs
- 5 vials, 30 vials
- Marketing authorisation holder
- Curium
- Manufacturer
- Curium
- Origin register
- US FDA, United States
- Storage
- Technescan HDP is available as: • 5 vials per carton (NDC 69945-091-20) • 30 vials per carton (NDC 69945-091-40) Before radiolabeling, store at 20°C to 25°C (68°F to 77°F). After radiolabeling, store vial upright in appropriate shielding at 20°C to 25°C (68°F to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 13 October 2015
- Identifiers
- DailyMed set ID 6fc2e41e-a1bf-4e0f-924a-88be0372d4afNDC 69945-091Application NDA018321
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Oxidronate is a prescription medicine indicated for skeletal imaging to demonstrate areas of altered osteogenesis in adult and pediatric patients. It is available as powder for injection for intravenous use. MedsAcross supplies Oxidronate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about OxidronateFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Technescan HDP prescribing information (Curium) · U.S. National Library of Medicine, DailyMed
Need Technescan HDP 3.15 mg powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.